Antiretroviral switching and bedaquiline treatment of drug-resistant tuberculosis HIV co-infection

Bedaquiline, a potent new therapy for drug-resistant tuberculosis, results in improved survival including in HIV patients with multidrug and extensively drug-resistant tuberculosis. In line with WHO recommendations, in South Africa and other low-income and middle-income settings, antiretroviral ther...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Lancet HIV
Hoofdauteurs: O’Donnell, Max R, Padayatchi, Nesri, Daftary, Amrita, Orrell, Catherine, Dooley, Kelly E, Amico, K Rivet, Friedland, Gerald
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2019
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7155388/
https://ncbi.nlm.nih.gov/pubmed/30846058
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2352-3018(19)30035-9
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items